Head-to-Head

Abbott Laboratories vs. Lyell Immunopharma, Inc. Common Stock

ABT

Abbott Laboratories

$115.51 +5.59%

VS LYEL

Lyell Immunopharma, Inc. Common Stock

$15.43 +43.27%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTLYEL
Market Cap $189.30 billion $263.92 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTLYEL
Dividend Yield 2.18% —

ABT and LYEL split the dividend factors evenly.

Risk & Sentiment

ABTLYEL
Short Interest 0.57% 5.38%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, LYEL overview, LYEL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.